CU20210040A7 - COMPOUNDS FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH NLRP ACTIVITY - Google Patents

COMPOUNDS FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH NLRP ACTIVITY

Info

Publication number
CU20210040A7
CU20210040A7 CU2021000040A CU20210040A CU20210040A7 CU 20210040 A7 CU20210040 A7 CU 20210040A7 CU 2021000040 A CU2021000040 A CU 2021000040A CU 20210040 A CU20210040 A CU 20210040A CU 20210040 A7 CU20210040 A7 CU 20210040A7
Authority
CU
Cuba
Prior art keywords
compounds
treatment
conditions associated
nlrp
activity
Prior art date
Application number
CU2021000040A
Other languages
Spanish (es)
Inventor
Shomir Ghosh
Gary Glick
Jason Katz
William Roush
Hans Seidel
Dong-Ming Shen
Shankar Venkatraman
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Priority claimed from PCT/US2019/060770 external-priority patent/WO2020102096A1/en
Publication of CU20210040A7 publication Critical patent/CU20210040A7/en

Links

Landscapes

  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)

Abstract

<p>En un aspecto, se presentan compuestos de la fórmula AA,</p> <p>Fórmula AA</p> <p>en donde las variables que se muestran en la Fórmula A pueden definirse como en cualquier lugar del presente documento.</p><p>In one aspect, compounds of formula AA are presented,</p> <p>Formula AA</p> <p>wherein the variables shown in Formula A can be defined as anywhere in the present document.</p>

CU2021000040A 2018-11-13 2019-11-11 COMPOUNDS FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH NLRP ACTIVITY CU20210040A7 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201862760244P 2018-11-13 2018-11-13
US201862760248P 2018-11-13 2018-11-13
US201862760209P 2018-11-13 2018-11-13
PCT/US2019/060770 WO2020102096A1 (en) 2018-11-13 2019-11-11 Compounds and compositions for treating conditions associated with nlrp activity

Publications (1)

Publication Number Publication Date
CU20210040A7 true CU20210040A7 (en) 2021-12-08

Family

ID=79171359

Family Applications (1)

Application Number Title Priority Date Filing Date
CU2021000040A CU20210040A7 (en) 2018-11-13 2019-11-11 COMPOUNDS FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH NLRP ACTIVITY

Country Status (1)

Country Link
CU (1) CU20210040A7 (en)

Similar Documents

Publication Publication Date Title
ECSP21033236A (en) COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH THE ACTIVITY OF NLRP
CU20200004A7 (en) COMPOUNDS TO TREAT CONDITIONS ASSOCIATED WITH NLRP ACTIVITY
CO2019008783A2 (en) Cyclic dinucleotide compounds for the treatment of cancer
CL2019001709A1 (en) Pyrazole derivatives as malt1 inhibitors.
CU24408B1 (en) DIHYDROISOQUINOLINONA SUBSTITUTED COMPOUNDS
CL2018002794A1 (en) Bicyclic compounds
BR112019002357A2 (en) heat treatment raw material purification
UY34657A (en) ? MACROCYCLIC DERIVATIVES FOR THE TREATMENT OF DISEASES ?.
CO2017001884A2 (en) Polymorphs of selinexor
CL2017002786A1 (en) Cross reference to related requests
BR112018010118A2 (en) cxcr2 inhibitors
UY35630A (en) PRIMARY CARBOXAMIDS AS BTK INHIBITORS
BR112017010354A2 (en) triazolopyrimidine compounds and uses thereof
CU24411B1 (en) COMPOSITE DERIVED FROM BENZAMIDE REPLACED WITH 1,3-TIAZOL-2-ILO USEFUL FOR THE TREATMENT OF NEUROGENIC DISORDERS
BR112016023558A2 (en) compounds useful as immunomodulators
UY35815A (en) ? OPTIMAL LOCKS OF CORN?
UY34593A (en) APELINE SYNTHETIC MIMETICS FOR CARDIAC FAILURE TREATMENT
UY34201A (en) AZAINDOL COMPOUNDS AND METHODS FOR HIV TREATMENT.
ECSP20046463A (en) COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING DISEASES INVOLVING TISSUES WITH ACIDIC OR HYPOXIC DISEASES
UY35908A (en) GPR6 TETRAHYDROPIRIDOPIRAZIN MODULATORS
BR112018002461A2 (en) compounds for optically active devices
ECSP17010238A (en) NOVELTY PYRIMIDINE COMPOUNDS REPLACED
CO2020012593A2 (en) Oxadiazoline derivatives
CO2017001506A2 (en) Novel substituted pyrimidine compounds
UY36348A (en) DERIVATIVES OF BENZOTIOFENYL SUBSTITUTED AS AGONISTS OF THE GPR40 FOR THE TREATMENT OF TYPE II DIABETES